Sign in
SEEL Stock Price, Chart, Stats & News
Seelos Therapeutics, Inc.
Save
214,970
Market cap
–
Current P/E
–
Forward P/E
SEEL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -1267.09% |
Operating margin | -1838.36% |
Pretax margin | -1719.56% |
Net margin | -1719.56% |
Effective tax rate | – |
ROA | -699.19% |
ROE | 171.72% |
D/E | -0.42x |
Interest coverage ratio | -539.99x |
SEEL valuation
P/E | – |
P/S | 0.10x |
P/B | -0.05x |
P/CF | -0.08x |
P/FCF | -0.01x |
P/OCF | -0.08x |
PEG | -0.00x |
EV multiple | 0.29x |
About
Seelos Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to the discovery, development, and eventual commercialization of innovative therapies. These treatments primarily target central nervous system (CNS), respiratory, and various other medical conditions. The company's pipeline includes several key clinical-stage candidates.
Similar securities
Based on sector and market capitalization
Report issue